<?xml version="1.0" encoding="UTF-8"?><item href="/insights/posts/mental_health_therapeutics_is_psilocybin_the_next_market_disruptor.php" dsn="blogs"><featured/><title>Mental Health Therapeutics: Is Psilocybin the Next Market Disruptor?</title><description>This research suggests that psilocybin reform is associated with a shift away from LSD and MDMA toward psilocybin, indicating that policy changes may reshape competitive dynamics and commercialization strategies in the emerging psychedelic therapeutics market.</description><pubDate>04/14/2026</pubDate><image><img src="https://walton.uark.edu/insights/posts/images/mentalhealththerapeutics_913x485_72dpi.jpg" alt="Silhouette of a head with a networked brain containing a pill, set against a backdrop of rising bar graphs, symbolizing mental enhancement and growth."/></image><author>Ashutosh Bhave</author><tags><tag>entrepreneurship</tag><tag>marketing</tag><tag>research</tag></tags></item>